In this study, CBR3-AS1 was found to be remarkably upregulated in CRC tissues and cell lines, and its high expression was closely correlated with poor prognosis and adverse clinicopathological features of CRC patients. The gene discussed is CBR3; the disease is colorectal carcinoma.